As pharmaceutical manufacturers face increasing pressure to improve patient access, SampliFi Rx today announced the launch of its digital, first-free prescription platform that eliminates the need for physical product samples. By enabling HCPs to write fully registered no-cost, first-fill prescriptions processed through the standard pharmacy system and delivered directly to patients, SampliFi brings greater compliance, visibility, and efficiency to an area long challenged by fragmentation and waste.
With unmatched visibility across the full prescription lifecycle—from the first-free fill through ongoing therapy—SampliFi Rx transforms traditional sampling into a measurable patient acquisition channel. Each SampliFi transaction is tracked at the individual prescription level, providing manufacturers with audit-ready records, automated compliance controls, and real-time oversight that reduces risk while improving operational efficiency.
“SampliFi Rx represents a fundamental shift in how the industry thinks about patient access and sample distribution,” said Joe Macaluso, CEO, SampliFi Rx. “This tool empowers manufacturers to replace or augment traditional sampling programs with a modern patient acquisition tool that delivers immediate value, end-to-end visibility, and long-term measurable impact.”
How SampliFi Rx Works:
- Prescription-First Model: HCPs issue a no-cost, first-fill prescription like any standard Rx, processed through existing pharmacy systems via ProCare Rx, SampliFi's prescription adjudication and processing partner, eliminating paper vouchers, sample closets, and rep drop-offs.
- Direct-to-Patient Fulfillment: Prescriptions are shipped directly to the patient’s home, removing access barriers and supporting faster therapy initiation.
- Actionable Data & Insights: Through the SampliFi platform, manufacturers gain real-time visibility into uptake, persistence, and ROI starting with the very first prescription.
- A Bridge to Patient Care: Interested patients can also request medications directly from the physician that is treating them for their illness. These requests can be made digitally from home, work or the prescriber's office.
Key Benefits:
- Streamlines Access: Improves speed and convenience for both HCPs and patients.
- Supports Compliance: Fully registered prescriptions processed through existing pharmacy infrastructure ensure regulatory rigor.
- Drives Commercial Impact: A scalable solution that helps teams track patient acquisition, optimize marketing spend, and demonstrate measurable outcomes.
Availability
SampliFi Rx is available now for early enterprise partners. To learn more or request a demo of the SampliFi platform, contact: Mykka Garrity, Product Director at [email protected].
SampliFi Rx is a division of Blockchain Applied Technologies and was developed by industry veterans with deep experience supporting pharmaceutical sales, marketing, and sampling operations. The company’s founders previously built and scaled four INC 500 companies, including The Phoenix Companies and The Macaluso Group, delivering data-driven solutions across sample fulfillment, sales enablement, and patient access programs.